What is CBC? Cannabichromene (CBC) belongs to the large family of cannabinoids the cannabis plant produces, alongside THC and CBD. It doesn't cause a high, it usually appears in small amounts, and it has drawn steady interest from researchers. Most of that research is early-stage work in cells and animals, not people. Here's what CBC is, how it seems to act in the body, what scientists have tested so far and how to find it on a label or lab report.
What is CBC, and how does the plant make it?
Cannabinoids are made in the trichomes, the tiny resin glands that frost a cannabis flower. They share a common starting point: CBGA, the acid form of CBG, which is why CBG gets called the mother cannabinoid. Our guide to CBG tells that part of the story. Enzymes in the plant then convert CBGA into one of three acids: THCA, CBDA or CBCA.
CBCA is the raw, acidic form of CBC. Heat and drying knock a small piece off the molecule, a process called decarboxylation, and CBCA becomes CBC, the same way THCA becomes THC. For the bigger picture of how these compounds relate, start with our overview of the main types of cannabinoids.
Most strains make only small amounts of CBC. In a 2025 analysis of 178 retail flower samples from 52 Colorado dispensaries, CBC averaged 0.04% by weight, and the highest sample reached 0.35%. THC in those same samples averaged about 21%, so CBC is a very small slice of the total.
Does CBC get you high?
It doesn't. THC's high comes mainly from activating CB1, a cannabinoid receptor concentrated in brain areas such as the cortex, hypothalamus and cerebellum. CB2, by contrast, sits mainly on immune cells, including support cells in the brain. In cell experiments, CBC activated the related CB2 receptor but not CB1, and reviewers point out that this lack of CB1 activity is consistent with CBC not producing THC-like effects.
That doesn't mean CBC does nothing. "Psychoactive" simply means a substance acts on the brain or nervous system, and CBC interacts with several targets there. "Intoxicating" means a substance impairs you or produces a high, and research so far doesn't suggest CBC does that.
In a product that also contains THC, any high you feel comes from the THC. Some animal studies suggest CBC can strengthen certain THC effects, but no human study has shown that the small amounts in typical products change how THC feels.
How CBC acts in the body: CB2, TRPA1, TRPV1 and anandamide
Lab studies point to a handful of targets:
- CB2 receptors: CBC switched on CB2, a cannabinoid receptor tied mainly to the immune system, in cell experiments. Its affinity for CB2 is reported to be similar to THC's.
- TRPA1: a channel on sensory nerve cells that responds to irritants. CBC activated it at very low concentrations, making it more potent there than most cannabinoids tested.
- TRPV1: a heat-sensing channel. CBC activated it too, but only at much higher concentrations.
- Anandamide: your body makes its own cannabinoid-like messenger called anandamide. In lab work, CBC slowed cells' uptake of it, which in theory could leave more of it active for longer.
There's a big caveat. These effects were measured in cells, at concentrations researchers chose. It isn't clear that the amounts in everyday products reach those levels in the human body, and studies of how people absorb and process CBC are scarce.
What early research explores: inflammation, skin, nerve cells and microbes
Scientists have looked at CBC in several areas. Here's what kind of evidence exists for each:
| Area | Type of study | What researchers saw |
|---|---|---|
| Inflammation | Mice | Fewer signs of inflammation in several mouse models |
| Skin | Human oil-gland cells in a dish | Less oil production when the cells were pushed to overproduce |
| Nerve cells | Mouse neural stem cells in a dish | More cells survived as they matured |
| Microbes | Lab tests on bacteria | Activity against some bacteria, including a drug-resistant staph strain |
Inflammation
In mouse studies, CBC reduced inflammation-driven overactivity of the gut and lessened tissue damage in a chemically induced model of colitis. Researchers still aren't sure which receptor is responsible: studies have pointed to CB1, CB2 and TRPA1, and some data suggest other mechanisms entirely.
Skin
In a 2016 study, researchers grew human sebocytes, the cells that make skin oil, in the lab. CBC lowered their baseline oil production and blunted the extra oil production triggered by a fatty acid called arachidonic acid. That's a dish of cells, not a person's skin.
Nerve cells
A 2013 study found that CBC helped mouse neural stem cells survive as they matured in a dish, while holding back their development into support cells called astrocytes. The researchers linked the effect, at least in part, to adenosine signaling.
Microbes
In lab tests, CBC and its acid form showed activity against some bacteria, including MRSA, a drug-resistant staph strain, though in one study CBC had no effect on E. coli. Test-tube results like these are a long way from a usable medicine.
What it adds up to
Each of these is an early clue rather than a result you can count on. Cell and animal studies often fail to carry over to people, and the doses used in them don't map neatly onto a gummy or a joint.
Human research is thin. The main human data come from a study of a cannabis extract that happened to contain CBC alongside CBD and THC. It tracked how the body handled the compounds and how well people tolerated them, not whether anyone's health improved. A 2024 review in a pharmacology journal concluded that CBC products are widely used with little or no evidence of their safety or effectiveness.
None of this shows that CBC prevents, relieves or reverses any condition, and CBC isn't approved as a medicine. If you're pregnant or breastfeeding, take medications or manage a health condition, talk with a clinician before using any cannabis product.
CBC compared with CBD and THC
| CBC | CBD | THC | |
|---|---|---|---|
| Intoxicating? | No | No | Yes |
| Research depth | Mostly cell and animal studies | Extensive, including an approved medicine | Extensive, including approved medicines |
| Average in Colorado retail flower (2025 study) | 0.04% | 0.05% | About 21% |
The table shows why CBC gets less attention. It's present in tiny amounts, and its human research base is small. CBD and THC have been studied in people for decades, and medicines based on each have been approved by regulators for specific conditions.
The flower row holds a surprise: in THC-dominant retail flower, CBD can be nearly as scarce as CBC. If you're looking for any minor cannabinoid, CBD included, the lab report matters more than the strain name. CBC is one of several minor cannabinoids getting a closer look; our guide to CBN covers another.
Where CBC shows up: flower, concentrates and oils
You're most likely to find measurable CBC in products that keep the plant's broader chemistry:
- Flower: present in trace amounts, usually well under 1%.
- Concentrates: extraction concentrates cannabinoids, so CBC can climb higher. Concentrates in the 2025 Colorado study averaged 0.40% CBC, with a top value of 1.89%.
- Whole-plant extracts and full-spectrum oils: these keep a wide range of cannabinoids, so they may carry some CBC.
- Distillates and isolates: refined toward a single compound, so they may contain little or none.
Because the amounts are so small, CBC is rarely the reason to choose one product over another. If it matters to you, only the lab report can tell you what's there.
CBC in CBD oil: full-spectrum, broad-spectrum and isolate
Hemp CBD oils come in three main styles, and only two of them are likely to contain CBC:
- Full-spectrum: keeps the plant's range of cannabinoids and terpenes, plus a trace of THC. CBC may be among them.
- Broad-spectrum: keeps many of those compounds but removes or reduces the THC. CBC can remain.
- Isolate: purified CBD on its own, with no CBC.
Our guide to full-spectrum CBD explains each style in more depth. Full-spectrum products are often marketed with the "entourage effect," a theory that plant compounds work better together. Our explainer on the entourage effect looks at how well that idea holds up.
Reading a label or lab report for CBC
Labels are built around THC and CBD, and minor cannabinoids like CBC are optional extras that many producers skip. In the 2025 Colorado study, 84% of the 277 products examined listed none of the minor cannabinoids on the label.
The fuller picture lives on the certificate of analysis, the lab report for a product's batch. Here's what to look for:
- CBC and CBCA: CBC is the active form; CBCA is the raw acid form that heat converts.
- Units: results appear as a percentage or in milligrams per gram. One percent equals 10 mg per gram.
- ND or LOQ notes: "ND" means the lab didn't detect it, and an LOQ note means there was too little to measure precisely.
- Batch match: the batch or lot number on the report should match your package.
Our guide to reading a cannabis label covers the rest of the label, from THC totals to test dates. If a product's lab results leave you with questions, a budtender can help you read them.
